Cancer has a negative systemic impact on its host in addition to its local or metastatic effects, and no cancer complication is more ubiquitous than anaemia, a condition for which there is now a specific remedy, the recombinant growth factor erythropoietin.
Cancer-associated anemia has an adverse influence on survival regardless of tumour type. The pharmacological correction of anaemia with recombinant erythropoietin could promote tumour growth, whereas the use of tumour-necrosis (...)
Home > D. General pathology > Blood and immunity > Blood
Blood
-
cancer-associated anemia
31 January 2006 -
coagulation
18 January 2006blood coagulation
-
hemophilia A
18 January 2006Haemophilia A
-
hypereosinophilia
10 January 2006eosinophilia
-
hemolysis
3 January 2006Etiology (Exemples)
infectious hemolysis bacterial hemolysis Bartonella bacilliformis Streptococcus sp. Clostridium sp. Staphylococcus sp. Pneumococcus sp. Hemophilus influenzae B Shigella sp. Eschericcia coli Mycoplasma pneumonia Meningococcus sp. -
inherited bleeding disorders
14 June 2005disorders of platelet adhesion and aggregation
-
ALPS1B
27 January 2005ALPS1A
MIM.601859Descriptif : autosomal recessive autoimmune lymphoproliferative syndrome type 1B
-
ALPS1A
27 January 2005autosomal recessive autoimmune lymphoproliferative syndrome type 1A
-
stomatocytosis
26 January 2005Autosomal dominant hemolytic anemia.
Synopsis
shortened erythrocyte survival
increased erythrocyte osmotic fragility
-erythrocytes uniconcave with slitlike rather than circular area of central pallor in stained preparations
absent 28-kD integral protein from red cell membranes
increased intracellular sodium
Etiology
Locus 9q34.1 -
hereditary hemolytic anemias
26 January 2005hereditary haemolytic anaemias